Managing weight is easier said than done. People who go to doctors for help are sometimes prescribed Saxenda, which is also known by its generic name, liraglutide. Similar to Victoza, this medication works as a glucagon-like peptide-1 (GLP-1) receptor agonist, which primarily works to regulate your blood sugar levels. The difference between Saxenda and Victoza is that the first is manufactured specifically for weight loss management.
Saxenda is taken via subcutaneous daily injections. During the first week, patients are given a dose of 0.6 mg daily. The dosage increases for the next five weeks up until patients are finally able to take the maximum dosage of 3.0 mg daily.
While it is made for a different purpose compared to Victoza, it still shares the same active ingredient, liraglutide. Patients undergoing Saxenda treatment are prone to serious medical health conditions, including gastroparesis or stomach paralysis. It’s an untreatable disease that results in persistent abdominal pain and vomiting.
Saxenda is manufactured by Novo Nordisk, a tenured pharmaceutical company established in 1923. The company is a leading manufacturer of type 2 diabetes medications. Other than Saxenda, Novo Nordisk is also the maker of Ozempic, Rybelsus, and Victoza.
Have you been prescribed Saxenda for weight management? If you suffer from gastroparesis or other serious health conditions, you could be a potential claimant. Our team can review your case to check its eligibility for a Saxenda claim. To make the case strong, it needs to meet the following:
Your medical records should include evidence that you were prescribed Saxenda and records that show you’ve been diagnosed with gastroparesis, vision loss, or bowel obstruction after the treatment.
People are taking a stand against these weight loss drugs that have become more popular in the last couple of years. One of whom is Jacqueline Barber, who was prescribed Ozempic, a similar medication from the same manufacturer. It didn’t take long for the symptoms of gastroparesis to show. With the help of her legal team, Barber took Novo Nordisk to court in June 2024.
As of February 2024, there are over 1,300 lawsuits against manufacturers of GLP-1 RA medications. These cases have been compiled under MDL 3094, making it easier for the court to continue with the proceedings.
Lawsuits can take a considerable amount of time. Without a strong case, you could end up wasting precious time and resources. Our team will help you understand how strong your eligibility is for a claim. To start, just prepare your medical records and reach out to us immediately. If our team deems your case strong, we’ll set you up with an attorney.
10 Minutes Over the Phone
*No fees unless compensation is obtained